Brochure Summary of Amisulpride
The brochure is intended to teach adult patients on the drug that is indicated for prevention and treatment of postoperative nausea and vomiting (PONV) either alone or through combination with antiemetics. It is also used to teach the adult patients who are diagnosed with psychotic diseases and is put on treatment with amisulpride. The brochure is additionally intended to teach the nursing staff and the physicians on better ways to administer the drug and perform proper patient care and educational practice. the first part of the brochure highlights on the key details of the drug, which is a key step for the student nurses and other clinical students on getting on the key steps of analyzing pharmacology for nursing practice. The brochure explores details on the drug considerations, lab effects, drug interactions, toxicities, pharmacokinetics, pharmacodynamics, and critical aspects of pharmacotherapeutics. The in-depth analysis of the drug details and pharmacotherapeutic helps student nurses to comprehensively understand the drug analogy and know when to use it in the patient management.
The second part of the brochure is also significant for the nursing students because it offers details on the patient education regarding amisulpride. Notably, patient education on a drug use is a critical safety measure used to timely arrest some of the adverse reaction aligned to a drug. In this brochure, key emphasis is given to proper patient education with regards to all details of the drug. The aspect of special consideration highlighted in this brochure is equally effective in conductive effective nursing management process. The patients diagnosed with PONV are thus taught from the brochure on accurate reporting of side effects, correct reporting of adverse events or unsuspected serious adverse events that may require urgent attention, and most importantly, home monitoring of the key vital signs.
References
Fox, G. M., Albayaty, M., Walker, J. L., Xue, H., & Darpo, B. (2019). Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting. Anesthesia and Analgesia.
Fox, G., & Kranke, P. (2020). A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting. Expert Review of Clinical Pharmacology, 1-10.
Smyla, N., Koch, T., Eberhart, L. H., & Gehling, M. (2020). An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting. Expert Opinion on Pharmacotherapy, 21(5), 517-522.